The Effects of Resveratrol Supplementation on Measurements of Health and Human Performance
NCT ID: NCT01244360
Last Updated: 2011-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
44 participants
INTERVENTIONAL
2010-11-30
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resveratrol for Improved Performance in the Elderly
NCT01126229
Effect of Resveratrol Supplementation on Exercise Performance and Recovery
NCT06723119
Evaluating the Clinical Efficacy of Resveratrol in Improving Metabolic and Skeletal Muscle Function in Patients With Heart Failure
NCT03525379
Resveratrol Supplementation on Exercise in Healthy Sedentary Adults
NCT01615445
Effect of Resvida, a Comparison With Calorie Restriction Regimen
NCT00823381
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* blood laboratory parameters
* cognitive assessment changes
* body composition changes
* vascular endothelial response
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sugar Pill
Subject will take placebo for daily for 4 weeks, with optional additional 4 week treatment period.
Placebo Comparator: Sugar Pill
Subject will take placebo for daily for 4 weeks, with optional additional 4 week treatment period.
Dietary Supplement: resveratrol
Subject will take resveratrol supplement for 4 weeks, with optional additional 4 week treatment period.
resveratrol
Subject will take resveratrol supplement for 4 weeks, with optional additional 4 week treatment period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
resveratrol
Subject will take resveratrol supplement for 4 weeks, with optional additional 4 week treatment period.
Placebo Comparator: Sugar Pill
Subject will take placebo for daily for 4 weeks, with optional additional 4 week treatment period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal heart rate and Blood pressure
* Ability to use personal computer interface
* Successful completion of physical activity readiness questionnaire
Exclusion Criteria
* inability to tolerate exercise
* have taken grape related supplement in past 12 months
* current use of drugs or dietary supplements to enhance exercise performance
* allergy to wine, grape juice or grape seed supplements
45 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marywood University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marywood University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James Smoliga, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Marywood University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marywood University
Scranton, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2RESMU194218
Identifier Type: OTHER
Identifier Source: secondary_id
MU Smoliga Resveratrol
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.